UnitedHealth Group Incorporated (NYSE:UNH) – Oppenheimer Holdings increased their FY2017 earnings estimates for shares of UnitedHealth Group in a report released on Tuesday. Oppenheimer Holdings analyst M. Wiederhorn now anticipates that the healthcare conglomerate will post earnings of $9.97 per share for the year, up from their previous estimate of $9.88. Oppenheimer Holdings has a “Outperform” rating and a $205.00 price objective on the stock.

UNH has been the topic of several other research reports. Barclays PLC lifted their target price on shares of UnitedHealth Group from $200.00 to $217.00 and gave the company an “overweight” rating in a report on Wednesday, July 19th. Leerink Swann restated a “buy” rating and set a $240.00 target price (up previously from $225.00) on shares of UnitedHealth Group in a report on Wednesday. Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $219.00 target price on the stock in a report on Thursday, September 21st. Cowen and Company restated a “buy” rating on shares of UnitedHealth Group in a report on Friday, July 14th. Finally, Cantor Fitzgerald lifted their target price on shares of UnitedHealth Group to $225.00 and gave the company an “overweight” rating in a report on Wednesday. Three research analysts have rated the stock with a hold rating and twenty-four have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average target price of $212.40.

ILLEGAL ACTIVITY WARNING: “FY2017 Earnings Forecast for UnitedHealth Group Incorporated (UNH) Issued By Oppenheimer Holdings” was first reported by American Banking News and is owned by of American Banking News. If you are reading this news story on another site, it was copied illegally and republished in violation of United States & international copyright and trademark law. The correct version of this news story can be viewed at https://www.americanbankingnews.com/2017/10/19/fy2017-earnings-forecast-for-unitedhealth-group-incorporated-unh-issued-by-oppenheimer-holdings.html.

UnitedHealth Group (UNH) opened at 205.23 on Thursday. UnitedHealth Group has a 12-month low of $133.03 and a 12-month high of $207.80. The firm has a market capitalization of $198.43 billion, a PE ratio of 24.66 and a beta of 0.63. The company has a 50-day moving average price of $196.96 and a 200-day moving average price of $185.50.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, October 17th. The healthcare conglomerate reported $2.66 EPS for the quarter, beating analysts’ consensus estimates of $2.57 by $0.09. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The firm had revenue of $50.32 billion for the quarter, compared to analysts’ expectations of $50.38 billion. During the same period in the prior year, the firm posted $2.17 earnings per share. The firm’s quarterly revenue was up 8.7% on a year-over-year basis.

Several institutional investors and hedge funds have recently added to or reduced their stakes in UNH. Harbour Capital Advisors LLC increased its position in shares of UnitedHealth Group by 18,383.4% in the 2nd quarter. Harbour Capital Advisors LLC now owns 2,516,706 shares of the healthcare conglomerate’s stock worth $13,573,000 after purchasing an additional 2,503,090 shares during the last quarter. Janus Henderson Group PLC increased its position in shares of UnitedHealth Group by 1,820.1% in the 2nd quarter. Janus Henderson Group PLC now owns 2,388,641 shares of the healthcare conglomerate’s stock worth $442,896,000 after purchasing an additional 2,264,242 shares during the last quarter. Vanguard Group Inc. increased its position in shares of UnitedHealth Group by 2.5% in the 2nd quarter. Vanguard Group Inc. now owns 64,578,618 shares of the healthcare conglomerate’s stock worth $11,974,168,000 after purchasing an additional 1,588,516 shares during the last quarter. Parametric Portfolio Associates LLC increased its position in shares of UnitedHealth Group by 77.3% in the 2nd quarter. Parametric Portfolio Associates LLC now owns 3,584,134 shares of the healthcare conglomerate’s stock worth $664,570,000 after purchasing an additional 1,562,661 shares during the last quarter. Finally, Jennison Associates LLC increased its position in shares of UnitedHealth Group by 180.4% in the 2nd quarter. Jennison Associates LLC now owns 2,252,507 shares of the healthcare conglomerate’s stock worth $417,660,000 after purchasing an additional 1,449,130 shares during the last quarter. 86.11% of the stock is owned by institutional investors.

In other news, insider Larry C. Renfro sold 50,574 shares of the business’s stock in a transaction dated Friday, September 15th. The shares were sold at an average price of $198.11, for a total value of $10,019,215.14. Following the completion of the sale, the insider now owns 195,625 shares of the company’s stock, valued at approximately $38,755,268.75. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director William C. Ballard, Jr. sold 5,000 shares of the business’s stock in a transaction dated Thursday, August 3rd. The stock was sold at an average price of $193.98, for a total transaction of $969,900.00. Following the completion of the sale, the director now directly owns 76,058 shares of the company’s stock, valued at approximately $14,753,730.84. The disclosure for this sale can be found here. Insiders sold a total of 76,174 shares of company stock valued at $14,981,909 in the last three months. Insiders own 0.89% of the company’s stock.

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 19th. Stockholders of record on Friday, September 8th were given a $0.75 dividend. This represents a $3.00 annualized dividend and a dividend yield of 1.46%. The ex-dividend date was Thursday, September 7th. UnitedHealth Group’s payout ratio is currently 33.26%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Earnings History and Estimates for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.